Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis

Journal of Gastrointestinal Surgery

Volumn 13, Issue 8, 2009, Pages 1480-1486

  Kashyap, Randeep ^a   Mantry, Parvez ^b   Sharma, Rajeev ^a   Maloo, Manoj K ^c   Safadjou, Saman ^a   Qi, Yanjie ^a   Jain, Ashok ^d   Maliakkal, Benedict ^a   Ryan, Charlotte ^a   Orloff, Mark ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b METHODIST DALLAS MEDICAL CENTER   (United States)

^c GEISINGER MEDICAL CENTER   (United States)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Deceased donor; Liver transplant; Living donor; Outcomes; Primary sclerosing cholangitis; Recurrence

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCLEROSING CHOLANGITIS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

ADULT; CHOLANGITIS, SCLEROSING; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 70349428443     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-0898-3     Document Type: Article

References (33)

1. Chapman RW, Arborgh BA, Rhodes JM, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980;21(10):870. doi:10.1136/gut.21.10.870.
2. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995;332(14):924. doi:10.1056/NEJM199504063321406.
3. Wiesner RH PM LN, Ludwig J. Primary sclerosing cholangitis. Diseases of the Liver: Lippincot 1993:411.
4. Bjoro K, Schrumpf E. Liver transplantation for primary sclerosing cholangitis. J Hepatol 2004;40(4):570. doi:10.1016/j.jhep.2004.01.021.
5. Goss JA, Shackleton CR, Farmer DG, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 1997;225(5):472. doi:10.1097/00000658-199705000-00004.
6. Graziadei IW, Wiesner RH, Marotta PJ, et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999;30(5):1121. doi:10.1002/hep.510300501.
7. Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology 1995;22(2):451. doi:10.1002/hep.1840220213.
8. Graziadei IW, Wiesner RH, Batts KP, et al. Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 1999;29(4):1050. doi:10.1002/hep.510290427.
9. Harrison RF, Davies MH, Neuberger JM, Hubscher SG. Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis? Hepatology 1994;20(2):356. doi:10.1002/hep.1840200214.
10. Kugelmas M, Spiegelman P, Osgood MJ, et al. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2003;9(7):727. doi:10.1053/jlts.2003.50143.
11. Sheng R, Campbell WL, Zajko AB, Baron RL. Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: evidence of recurrent disease. AJR Am J Roentgenol 1996;166(5):1109.
12. Yamagiwa S, Ichida T. Recurrence of primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation in Japan. Hepatol Res 2007;37(Suppl 3):S449. doi:10.1111/j.1872-034X.2007.00250.x.
13. Hayashi PH, Forman L, Steinberg T, et al. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl 2003;9(7):737. doi:10.1053/jlts.2003.50122.
14. Maheshwari A, Yoo HY, Thuluvath PJ. Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC. Am J Gastroenterol 2004;99(3):538. doi:10.1111/j.1572-0241.2004.04050.x.
15. Moon DB, Lee SG. Adult-to-adult living donor liver transplantation at the Asan Medical Center. Yonsei Med J 2004;45(6):1162.
16. Soejima Y, Harada N, Shimada M, et al. Perioperative management and complications in donors related to living-donor liver transplantation. Surgery 2002;131(1):S195. doi:10.1067/msy.2002.119576.
17. Solano E, Khakhar A, Bloch M, et al. Liver transplantation for primary sclerosing cholangitis. Transplant Proc 2003;35(7):2431. doi:10.1016/j.transproceed.2003.09.017.
18. Jeyarajah DR, Netto GJ, Lee SP, et al. Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process? Transplantation 1998;66(10):1300. doi:10.1097/00007890-199811270-00006.
19. Kubota T, Thomson A, Clouston AD, et al. Clinicopathologic findings of recurrent primary sclerosing cholangitis after orthotopic liver transplantation. J Hepatobiliary Pancreat Surg 1999;6(4):377. doi:10.1007/s005340050134.
20. Liden H, Norrby J, Friman S, Olausson M. Liver transplantation for primary sclerosing cholangitis-a single-center experience. Transpl Int 2000;13(Suppl 1):S162. doi:10.1007/s001470050314.
21. Vera A, Moledina S, Gunson B, et al. Risk factors for recurrence of primary sclerosing cholangitis of liver allograft. Lancet 2002;360(9349):1943. doi:10.1016/S0140-6736(02)11861-7.
22. Yusoff IF, House AK, De Boer WB, et al. Disease recurrence after liver transplantation in Western Australia. J Gastroenterol Hepatol 2002;17(2):203. doi:10.1046/j.1440-1746.2002.02632.x.
23. Akyildiz M, Karasu Z, Cagirgan S, Kilic M, Tokat Y. Rituximab therapy for life-threatining immune hemolytic anemia in a liver tranplant recipient: a case report. Transplant Proc 2004;36(5):1492. doi:10.1016/j.transproceed.2004.05.042.
24. Heimbach JK, Menon KV, Ishitani MB, et al. Living donor liver transplantation using a right lobe graft in an adult with situs inversus. Liver Transpl 2005;11(1):111. doi:10.1002/lt.20313.
25. Ikegami T, Nishizaki T, Yanaga K, et al. Living-related auxiliary partial orthotopic liver transplantation for primary sclerosing chonangitis-subsequent removal of the native liver. Hepatogastroenterology 1999;46(29):2951.
26. Jabbour N, Gagandeep S, Mateo R, et al. Live donor liver transplantation: staging hepatectomy in a Jehovah's Witness recipient. J Hepatobiliary Pancreat Surg 2004;11(3):211. doi:10.1007/s00534-003-0877-0.
27. Kaibori M, Uemoto S, Fujita S, et al. Native hepatectomy after auxiliary partial orthotopic liver transplantation. Transpl Int 1999;12(5):383. doi:10.1111/j.1432-2277.1999.tb00626.x.
28. Nakamura M, Fuchinoue S, Nakajima I, et al. Three cases of sequential liver-kidney transplantation from living-related donors. Nephrol Dial Transplant 2001;16(1):166. doi:10.1093/ndt/16.1.166.
29. Oya H, Sato Y, Yamamoto S, Takeishi T, Kobayashi T, Hatakeyama K. Living related donor liver transplantation for primary sclerosing cholangitis with hepatocellular carcinoma and Crohn's disease: a case report. Transplant Proc 2004;36(8):2297. doi:10.1016/j.transproceed.2004.07.041.
30. Tamura S, Sugawara Y, Kaneko J, Matsui Y, Togashi J, Makuuchi M. Recurrence of primary sclerosing cholangitis after living donor liver transplantation. Liver Int 2007;27(1):86. doi:10.1111/j.1478-3231.2006.01395.x.
31. Varotti G, Gondolesi GE, Roayaie S, et al. Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis. J Am Coll Surg 2003;197(5):765. doi:10.1016/j.jamcollsurg.2003.06.001.
32. Wachs ME, Bak TE, Karrer FM, et al. Adult living donor liver transplantation using a right hepatic lobe. Transplantation 1998;66(10):1313. doi:10.1097/00007890-199811270-00008.
33. Boberg KM, Lundin KE, Schrumpf E. Etiology and pathogenesis in primary sclerosing cholangitis. Scand J Gastroenterol Suppl 1994;204:47. doi:10.3109/00365529409103625.